OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO

Compounds are provided having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein A, B, L, R3, R4, R5, R6, R8, m and n are as defined herein. Such compounds modulate the opioid receptor, particulare the mu-opioid recept...

Full description

Saved in:
Bibliographic Details
Main Authors SEIDL, Frederick, BHATT, Ulhas, NGUYEN, Thomas, SPERANDIO, David, WEI, Zhi-Liang, DING, Pingyu, NERURKAR, Alok, DUQUETTE, Jason, SADLOWSKI, Corinne, MEDINA, Julio Cesar, LI, Yihong, WANG, Xiaodong, MCGEE, Larry
Format Patent
LanguageEnglish
French
Published 10.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Compounds are provided having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein A, B, L, R3, R4, R5, R6, R8, m and n are as defined herein. Such compounds modulate the opioid receptor, particulare the mu-opioid receptor (MOR) and/or the kappa-opioid receptor (KOR), and/or the delta-opioid receptor (DOR). Products containing such compounds, as well as methods for their use and preparation, are also provided. La présente invention concerne des composés représentés par la formule (I) : ou un isomère, racémate, hydrate, solvate, isotope ou sel pharmaceutiquement acceptables de ceux-ci, dans la formule A, B, L, R3, R4, R5, R6, R8, m et n sont tels que définis dans la description. Les composés selon l'invention sont des modulateurs du récepteur opioïde, en particulier le récepteur mu-opioïde (MOR) et/ou le récepteur kappa-opioïde (KOR), et/ou le récepteur delta-opioïde (DOR). L'invention concerne également des produits contenant de tels composés, ainsi que des procédés se rapportant à leur utilisation et leur préparation.
AbstractList Compounds are provided having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein A, B, L, R3, R4, R5, R6, R8, m and n are as defined herein. Such compounds modulate the opioid receptor, particulare the mu-opioid receptor (MOR) and/or the kappa-opioid receptor (KOR), and/or the delta-opioid receptor (DOR). Products containing such compounds, as well as methods for their use and preparation, are also provided. La présente invention concerne des composés représentés par la formule (I) : ou un isomère, racémate, hydrate, solvate, isotope ou sel pharmaceutiquement acceptables de ceux-ci, dans la formule A, B, L, R3, R4, R5, R6, R8, m et n sont tels que définis dans la description. Les composés selon l'invention sont des modulateurs du récepteur opioïde, en particulier le récepteur mu-opioïde (MOR) et/ou le récepteur kappa-opioïde (KOR), et/ou le récepteur delta-opioïde (DOR). L'invention concerne également des produits contenant de tels composés, ainsi que des procédés se rapportant à leur utilisation et leur préparation.
Author SADLOWSKI, Corinne
LI, Yihong
MEDINA, Julio Cesar
SEIDL, Frederick
MCGEE, Larry
WEI, Zhi-Liang
SPERANDIO, David
NERURKAR, Alok
NGUYEN, Thomas
WANG, Xiaodong
DING, Pingyu
BHATT, Ulhas
DUQUETTE, Jason
Author_xml – fullname: SEIDL, Frederick
– fullname: BHATT, Ulhas
– fullname: NGUYEN, Thomas
– fullname: SPERANDIO, David
– fullname: WEI, Zhi-Liang
– fullname: DING, Pingyu
– fullname: NERURKAR, Alok
– fullname: DUQUETTE, Jason
– fullname: SADLOWSKI, Corinne
– fullname: MEDINA, Julio Cesar
– fullname: LI, Yihong
– fullname: WANG, Xiaodong
– fullname: MCGEE, Larry
BookMark eNrjYmDJy89L5WRw9g_w9Pd0UQhydXYNCPEPUvD1dwn1cQSyghUc_VwUAoKAfOcQCMfXNcTD3yUYqBiowtVFIcTDNcg1xJ-HgTUtMac4lRdKczMou7mGOHvophbkx6cWFyQmp-allsSH-xsZGFoaWpqaGZs4GhoTpwoAFCEuZA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate MODULATEURS DU RÉCEPTEUR OPIOÏDE, PRODUITS ET PROCÉDÉS ASSOCIÉS
ExternalDocumentID WO2019195634A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2019195634A13
IEDL.DBID EVB
IngestDate Fri Sep 20 10:13:51 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2019195634A13
Notes Application Number: WO2019US25910
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191010&DB=EPODOC&CC=WO&NR=2019195634A1
ParticipantIDs epo_espacenet_WO2019195634A1
PublicationCentury 2000
PublicationDate 20191010
PublicationDateYYYYMMDD 2019-10-10
PublicationDate_xml – month: 10
  year: 2019
  text: 20191010
  day: 10
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies EPIODYNE, INC
RelatedCompanies_xml – name: EPIODYNE, INC
Score 3.2354164
Snippet Compounds are provided having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof,...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191010&DB=EPODOC&locale=&CC=WO&NR=2019195634A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dS8MwFL2MKeqbTsWPKQGlb8XZdq19GNIlKZ3YpXSZ7m2YroIg3XAV_743Xad72ltuLoQkcG7uyccJwK3lzh4spTqm7793TSfzXVN1vZmpMtfOMcVHDqH3O-KhG42dp0l30oDP9VuYSif0pxJHRERliPeyiteL_00sVt2tXN6pD6yaP4ayx4yaHSP5QH5hsH6PJ4IJalCKvM0YpisfcgHbCZAr7ehEWivt85e-fpey2FxUwkPYTbC9ojyCRl60YJ-u_15rwV5cH3ljsUbf8hioSAZiwEjKKU-kSEks2Pg5wNKIBENGkhRtKldGzGUk2IjoPzEwOhEZ8ZRLcQI3IZc0MrE307_BT1_FZtftU2gW8yI_A5Ij9hwPpzTTGviWrxBM6g3THa3o5ubeObS3tXSx3X0JB9rUUfq-04Zm-fWdX-HyW6rratZ-AVZugRg
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ3PT8IwFMdfCBrxpqjxB2oTzW6LCGNzB2JG22UoW5dRlBuxYyYmZhCZ8d_3dYBy4tb2JU3b5PvaT3-8Aty27OlDS6mm6brvHdNKXdtUHWdqqtRuZ7jER4bQ-x1hZAcj62ncGVfgc_0WpowT-lMGR0RFpaj3ovTX8_9NLFberVzcqQ8smj36ssuMFR0jfCBfGKzX5bFgghqUIrcZUbK0IQu0LQ9ZacdBKCxh6aWn36XMNycV_wB2Y6wvLw6hkuV1qNH132t12AtXR96YXKlvcQRUxH3RZyThlMdSJCQUbDTwMDUkXsRInGCeymUm5DIQbEj0nxjonYgMeMKlOIYbn0samNiayV_nJ69is-ntE6jmszw7BZKh9iwHhzTVMfBbrkIxqTdc7uiIbnbmnEFjW03n283XUAtkOJgM-tHzBexrk_bY980GVIuv7-wSp-JCXZUj-AuE3IQC
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=OPIOID+RECEPTOR+MODULATORS+AND+PRODUCTS+AND+METHODS+RELATED+THERETO&rft.inventor=SEIDL%2C+Frederick&rft.inventor=BHATT%2C+Ulhas&rft.inventor=NGUYEN%2C+Thomas&rft.inventor=SPERANDIO%2C+David&rft.inventor=WEI%2C+Zhi-Liang&rft.inventor=DING%2C+Pingyu&rft.inventor=NERURKAR%2C+Alok&rft.inventor=DUQUETTE%2C+Jason&rft.inventor=SADLOWSKI%2C+Corinne&rft.inventor=MEDINA%2C+Julio+Cesar&rft.inventor=LI%2C+Yihong&rft.inventor=WANG%2C+Xiaodong&rft.inventor=MCGEE%2C+Larry&rft.date=2019-10-10&rft.externalDBID=A1&rft.externalDocID=WO2019195634A1